US pharmaceuticals market to expand at just 1.8% CAGR in next five years, says BMI

The US pharmaceutical market remains ranked first, both regionally and globally, in Business Monitor International’s Pharmaceuticals & Healthcare Business Environment Ratings update for fourth-quarter 2010. This placement is a reflection of its massive potential and limited risks relative to other markets. The country's pharmaceutical spending reached almost $306 billion in 2009, notes BMI.

While the rate of spending will be modest over the coming five years, BMI forecasts a compound annual growth rate (CAGR) of just 1.76%, due to a combination of factors that include patent expirations and pending health care reform that will increase the role of the state in health care funding the market will reach $334 billion in value at consumer prices by 2014, thus remaining unparalleled globally.

Safety focus for regulator